Bruker to Acquire Carestream’s Preclinical In-vivo Imaging Business

News   Sep 24, 2012

 
Bruker to Acquire Carestream’s Preclinical In-vivo Imaging Business
 
 
 

RELATED ARTICLES

Researchers Reveal How Superbug Secretes It’s Toxin

News

Monash University’s Biomedicine Discovery Institute (BDI) researchers have created the first high-resolution structure depicting a crucial part of the ‘superbug’ Pseudomonas aeruginosa. The image identifies the ‘nanomachine’ used by the highly virulent bacteria to secrete toxins, pointing the way for drug design targeting this.

READ MORE

Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain Cancer

News

Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.

READ MORE

New Drug Class: Potential Therapeutics for Alzheimer’s Disease?

News

One step closer to an Alzheimer's treatment? Novel class of drugs more precisely blocks production of toxic forms of beta-amyloid.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE